SNBP, OPSY, VGPR, AMNP, BMGP, BNXR, BRGO, ZOOM, CNLG, HLCS, PWRM OTCPicks.com Daily Market Movers Digest Midday Report for Tuesday, November 17th

Our Stocks to Watch today include Sinobiopharma Inc. (OTCBB: SNBP), Optical Systems Inc. (OTC: OPSY), Vega Promotional Systems Inc. (OTC: VGPR), American Sierra Gold Corp. (OTCBB: AMNP), Biomagnetics Diagnostics Corp. (OTC: BMGP), Brinx Resources Ltd. (OTCBB: BNXR), Bergio International Inc. (OTCBB: BRGO), Zoom Technologies Inc. (Nasdaq: ZOOM), Conolog Corp. (Nasdaq: CNLG), Helicos BioSciences Corp. (Nasdaq: HLCS) and Power3 Medical Products Inc. (OTCBB: PWRM).

 

Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover’s Digest Newsletter and Email Stock Watch Alerts.

 

SINOBIOPHARMA INCORPORATED (OTCBB: SNBP)

"Up 28.00% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/SNBP.php 

 

Company Profile: http://www.otcpicks.com/sinobiopharma/sinobiopharma.htm 

 

Sinobiopharma, Inc. is a fully integrated and highly innovative specialty biopharmaceutical company engaged in the research and development, manufacture and marketing of biopharmaceutical products in China, the world's fastest growing pharmaceutical market. Known as Dong Ying (Jiangsu) Pharmaceutical Co., Ltd. in China, the Company's current therapeutic focus is on anesthesia-assisted agents and cardiovascular drugs.

 

SNBP News:

 

November 16 - Sinobiopharma has Production Rights to 23 Drugs Listed in China's National Essential Drugs List

 

All Drugs on List to be Covered by Basic Government Insurance That Will Cover 90 Percent of China's Population

 

Sinobiopharma, Inc. (OTCBB: SNBP) announced that 23 generic drugs for which the Company has production rights are listed in China's National Essential Drugs List, which covers pharmaceuticals used to treat up to 80 percent of the most common diseases in China.

 

According to the Chinese government's healthcare reform plan, 90 percent of China's citizens will be covered by a universal healthcare system by the year 2010. Under the plan, drugs on the National Essential Drugs List (the "List") will be purchased by various levels of government first, then distributed to medical facilities. All drugs on the List will be covered by the basic insurance plan supported by the government. The plan also calls for medical facilities to be upgraded, which includes the construction of 30,000 new hospitals, clinics and care centers across China.

 

"While Sinobiopharma is primarily focused on the development, production and distribution of "me-too/me-better" branded new or generic drugs with high margins, the inclusion of 23 generic drugs for which the Company owns production rights on the National Essential Drugs List, will enable us to increase both sales and margins," said Dr. Lequn Lee Huang, Sinobiopharma President and CEO. "We expect that this new advantage in the marketplace will also enable the Company to enhance our ability to improve return on investment for shareholders in 2010."

 

OPTICAL SYSTEMS INCORPORATED (OTC: OPSY)

"Up 20.00% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/OPSY.php 

 

Company Profile: http://www.otcpicks.com/optical-systems/optical-systems.htm

 

Optical Systems, Inc., through its operating subsidiary, Automotive Software Designers, Inc., develops technology and services for the automotive retail industry designed to maximize productivity and increase profits at auto dealerships. ASDI's flagship technology solution, Save-a-Deal, is a turnkey customer relationship management (CRM) tool for auto dealerships. Our business development center (BDC) provides a variety of services designed to help auto dealerships drive traffic to their showroom or Web site, retain customers and generate new streams of revenue.

 

OPSY News:

 

November 16 - Optical Systems, Inc. Launches New Version of Its Flagship CRM Product, Save-a-Deal

 

Save-a-Deal 2010 software product is designed to help dealerships retain customers and reduce sales costs

 

Automotive Software Designers, Inc., a leading provider of software and services for the automotive retail industry and a wholly owned subsidiary of Optical Systems, Inc. (OTC: OPSY), announced the launch of Save-a-Deal 2010, the latest version of its flagship, customer relationship management (CRM) software for automotive dealerships across the United States.

 

"The sooner-than-expected launch of Save-a-Deal 2010 is a huge milestone for the company," said B.J. Grisaffi, Chairman and Chief Executive Officer of Optical Systems, Inc. "We believe Save-a-Deal 2010 is the most robust CRM software solution for auto dealerships on the market today. We have already received inquiries from several, large automotive groups and expect to have a marketing agreement signed in the next few weeks to rapidly expand our presence into key markets within the U.S."

 

Save-a-Deal is a comprehensive, fully-integrated front office software solution specifically designed to increase auto dealerships' profitability. When properly used, this scalable CRM system is guaranteed to increase unit sales and profit-per-vehicle, while lowering costs through enhanced efficiency.

 

Save-a-Deal 2010 is a more streamlined, cost-effective CRM solution than its predecessor with added capabilities in remote personnel management, customer service, training, and security.

 

New features of Save-a-Deal 2010 include:

 

* Real-time access speeds with normal content loads of more than 200,000 database records from three different states with multiple, concurrent users.

* Added scalability from modular software architecture.

* Significant savings on installation and maintenance costs.

* Three levels of security to ensure protection of dealerships' sensitive data and information.

* More customization for electronic records management.

 

"Save-a-Deal 2010 enables auto dealerships to more effectively manage people and processes to achieve operational excellence," said Grisaffi.

 

VEGA PROMOTIONAL SYSTEMS INCORPORATED (OTC: VGPR)

"Up 8.97% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/VGPR.php 

 

Company Profile: http://www.otcpicks.com/Newsletter/VGPR_eProfile_110909.html

 

Vega Biofuels, Inc. (VGPR) was formed to pursue the production and sale of biofuel products throughout the world. With the growing need for clean energy, and the uncertain costs of fossil fuels, power generating plants around the world are looking at more useful and economical methods to run their power systems.

 

VGPR News:

 

November 17 - Trading Overview for Vega Promotional Systems Inc. Issued by Beacon Equity

 

BeaconEquity.com announces an investment report featuring Vega Promotional Systems Inc. (OTC: VGPR). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

 

Vega Promotional Systems Inc. (VGPR) engages in the production and sale of biofuel products worldwide. The Company manufactures energy efficient pellet fuel made from organic waste by-products. It offers bio-mass and bio-diesel products for power generation units.

 

In the report, the analyst notes:

 

"VGPR recently announced that its board of directors has approved a move from the Pink Sheets to the OTCBB. The Company is currently interviewing accounting firms to handle the audit associated with the move and hopes to have a firm secured in the next few days and will provide further updates as this matter progresses.

 

"The Company has applied for a grant from the State of Georgia under the federal State Energy Program to help fund the construction of the manufacturing plant. The U.S. Department of Energy announced July 7, 2009, that Georgia will receive $32.9 million in federal money to support energy efficiency and renewable energy projects across the state. The money is part of a total of nearly $82.5 million the department will award Georgia as part of the federal State Energy Program. Georgia's proposal outlined plans for increasing the use of renewable energy and reducing greenhouse gas emissions. The state will get more than $41 million in additional funding upon demonstrating successful implementation of the plan that will create green jobs, address state energy priorities and adopt emerging renewable energy and energy efficiency technologies; all of which are services that are provided by VGPR."

 

To read the entire report, visit www.beaconequity.com/i/VGPR.

 

November 16 - Vega Chooses ARE Energy to Provide Generators for Its 'Green Valley Project'

 

Vega Promotional Systems, Inc. (OTC: VGPR) announced the Company has narrowed its search for power producing generators for its "Green Valley Project" to ARE Energy.

 

The "Green Valley Project" is a multifaceted green energy power production facility that converts inexpensive methane gas from an abandoned coal mine into electricity and thermal energy. During the recent three year demonstration project, three generator sets were installed onsite in order to prove the viability of utilizing coal bed methane from the Green Valley mine as a sole source of fuel to generate electricity. Prior to Vega becoming involved in the project, the three generators were returned to the manufacturer.

 

Vega recently announced the addition of Robert Chew to oversee the redesign of the Green Valley Project. One change that will be made is that the power generating capacity of the facility will be increased by 100% to generate approximately 5 megawatts of power. Mr. Chew has narrowed the search for replacement generators to ARE Energy, a division of American Railroad Equipment. The two companies are currently designing two generator sets for the project that would produce 5 megawatts of power. Once operational, the power will be sold to the local power company.

 

Vega will provide additional details in the next few days concerning the delivery and set up of the generator sets.

 

AMERICAN SIERRA GOLD CORPORATION (OTCBB: AMNP)

 

Detailed Quote: http://www.otcpicks.com/quotes/AMNP.php 

 

Company Profile: http://www.otcpicks.com/american-sierra-gold/american-sierra-gold.htm

 

American Sierra Gold Corp. is a publicly traded independent gold exploration company headquartered in Reno, Nevada. Shareholders and prospective investors are encouraged to call investor relations at 1-888-279-3921 or visit American Sierra Gold Corp's website at www.americansierragold.com.

 

AMNP News:

 

November 17 - American Sierra Gold Corp. Discovers New Gold-Rich Zone at El Rosario, Urique Project

 

American Sierra Gold Corp. (OTCBB: AMNP), an independent gold exploration company headquartered in Reno, Nevada, announces the discovery of a new gold-rich zone within the El Rosario mine of the Company's Urique Project, Mexico.

 

The highlights of the completed work program include:

 

* 9.74 g/t Au and 356.7 g/t Ag over 1.68 m.

* 2.16 g/t Au and 92.5 g/t Ag over 2.93 m.

* 3.60 g/t Au and 108.2 g/t Ag over 1.87 m.

* 5.65 g/t Au and 95.9 g/t Ag over 0.45 m.

* 3.69 g/t Au and 112.7 g/t Ag over 1.10 m.

* 3.53 g/t Au and 243.1 g/t Ag over 0.40 m.

 

All the abovementioned results come from the underground sampling within the Rosario tunnel. This tunnel, the largest of three known workings within the El Rosario target area, was reconditioned, re-mapped and sampled in preparation for a planned underground drill program. Previously unknown extensions to the workings were encountered and sampled resulting in the discovery of the new gold-rich zone. A total of 22 samples were taken from this zone with values ranging from 0.06 to 11.57 g/t gold and 6.6 to 358.7 g/t silver.

 

The El Rosario target measures approximately 175 metres wide by 400 metres long and has never been drilled. It is open along strike and to depth. Multiple +1 kilogram per tonne silver assays have been collected from various veins throughout the El Rosario target. Significant silver mineralization also occurs within the altered andesite host rocks (257 g/t silver and 0.78 g/t gold over five metres), which adds to the bulk tonnage potential of the target. In 2008, surface sampling, some 150 metres above the Rosario tunnel, encountered bonanza grades of as much as 10.6 g/t gold and 8,290.0 g/t (or 241.5 ounces per ton) silver.

 

"We are very excited with the results of our work at El Rosario. The presence of multiple vein sets hosting high-grade silver-gold mineralization, as well as felsic intrusives related to widespread alteration and mineralization of the andesitic rocks, suggests that the El Rosario target area has the potential to expand further," commented Mr. Wayne Gruden, American Sierra's CEO.

 

"The new high-grade gold zone encountered may represent an ore shoot and this concept needs to be tested by drilling. We are, therefore, currently working on the preparation of an underground drilling program which we expect to initiate in the near-term and conclude in the first months of 2010," added Mr. Gruden.

 

BIOMAGNETICS DIAGNOSTICS CORPORATION (OTC: BMGP)

"Up 9.63% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/BMGP.php 

 

Company Profile: http://www.otcpicks.com/biomagnetics-diagnostics/biomagnetics-diagnostics.htm

 

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company's revolutionary diagnostic systems, which are based on advanced magnetics, test for any viral or bacterial disease using any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies.

 

BMGP News:

 

November 4 - Biomagnetics Applies for Gates Foundation Grand Challenge Grant

 

Biomagnetics Diagnostics Corp. (OTC: BMGP), a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, announced it has submitted an application to the Bill & Melinda Gates Foundation for a grant to further develop the Integrate Optical Biosensor Sensor (IOBS) technology it is plans to bring to market. The topic for the Grand Challenge Grant is Low Cost Diagnostics for Global Priory Health Conditions, which includes both malaria and tuberculosis.

“The availability of low cost diagnostics for malaria and tuberculosis are major concerns for not only health care professions, but also for the Gates Foundation. The technology we plan to introduce reduces the cost of traditional malaria testing by up to two-thirds,” commented Clayton Hardman, CEO of Biomagnetics Diagnostics. “The IOBS platform produces test results measured in only minutes, whereas traditional methodologies often take many days. Additionally, the handheld IOBS platform can be utilized in the field at point of care by relatively untrained personnel. We believe the IOBS platform holds the promise to revolutionize testing for not only malaria, but also for many other diseases including tuberculosis and HIV/AIDS. We believe the Gates Foundation had a device such as IOBS in mind when it devised the specifications for the Challenge Grant.”

 

According to the World Health Organization, some 3.2 billion people, or about half the world's population is at risk of malaria transmission in 107 countries and territories worldwide. While there are between 350 million and 500 million new cases of malaria each year, there are very few reliable and field deployable diagnostic tools available. In the case of malaria, early detection substantially improves treatability and survivability. Field deployable Integrated Optical Biosensor Systems (IBOS), such those Biomagnetics Diagnostics is planning to soon introduce hold the promise to significantly speed the diagnostic testing process and to meaningfully lower costs and improve lives.

 

BRINX RESOURCES LIMITED (OTCBB: BNXR)

"Up 46.67% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/BNXR.php

 

Brinx Resources is an expanding exploration and production company focused on developing North American and international oil and natural gas reserves. The Company's current focus is on the continued exploration and development of its land portfolio comprised of working interests in the 2008-3, 2009-2, and 2009-3 Oklahoma Projects (5% interest); Three Sands Project in Noble County, Oklahoma (40% interest); King City Project in California (20% interest); and the Palmetto Point and Belmont Lake Oil Field Projects in Mississippi (8 to 8.5% interest). Brinx Resources is seeking to further develop its existing projects through development or offset drilling and to expand its portfolio to include additional interests North America.

 

BNXR News:

 

November 17 - Brinx Resources and Partners Initiate Drilling of Two More Wells at Successful 2009-3 Oklahoma Project

 

Brinx Resources Ltd. (OTCBB: BNXR) (the "Company" or "Brinx") reports that the drilling of two new wells at the 2009-3 Oklahoma Project has commenced. These two well locations were based on positive anomalies discovered by 3-D seismic surveys and will target the same pay zones encountered in the Company's successful 2008-3 wells and the 2009-3-1 well.

 

As previously announced, the first of the three wells in 2009-3 Oklahoma Project drill program (2009-3-1) appears to have been a significant new discovery. Electric well logs and a drill stem test that flowed both oil and gas indicate the strong likelihood of another producing well for the Company. Logs also indicate that the well has as many as nine separate potential pay zones in three separate geological formations. The successful well from the 2008-3 program in the same area has been in production since May and has already produced over 65,000 barrels of oil and 7,400 mcf of gas.

 

"We are delighted by the initial success of our 2009-3 drill program," said Leroy Halterman, President of Brinx Resources. "All of the Oklahoma Project's well locations were targeted with modern 3-D seismic surveys and we are optimistic that our detailed geophysical analysis for the new wells will result in continued success for this program."

 

It is anticipated that the new wells (2009-3-2 and 2009-3-3) will take approximately two to three weeks to reach total depth. They will target the same pay zones as the successful wells in the 2008-3 program and the recently announced 2009-3-1 program. The Company should have preliminary indications as to the success of these wells once the drill reaches total depth and they are electrically logged.

 

BERGIO INTERNATIONAL INCORPORATED (OTCBB: BRGO)

"Up 47.38% in morning trading"

 

Detailed Quote: www.otcpicks.com/quotes/BRGO.php  

 

Bergio is a entering into its 20th year of operations and concentrates on boutique, upscale jewelry stores. It currently sells its jewelry to approximately 150 independent jewelry retailers across the United States. Bergio has spent millions in branding the Bergio brand through tradeshows, trade advertising, national advertising and billboard advertising since launching the line in 1995. Bergio has manufacturing control over our line as a result of having a manufacturing facility in New Jersey as well as subcontracts with facilities in Italy and Bangkok. We have establish Bergio International as a holding company for the purpose of acquiring established jewelry design and manufacturing firms who possess branded product lines. Additionally, Bergio intends to acquire design and manufacturing firms throughout the United States and Europe. If and when we pursue any potential acquisition candidates, we intend to target the top 10% of the world's jewelry manufactures that have already created an identity and brand in the jewelry industry.

 

BRGO News:

 

November 16 - Bergio International Goes Public

 

Bergio International, Inc. (OTCBB: BRGO) announced that the company has gone public and started trading on the "Over The Counter Bulletin Boards."

 

"We are very excited to take Bergio to the next level in its corporate growth. Going public will help us in our process of marketing Bergio to the world," stated Berge Abajian, CEO of Bergio International, Inc.

 

ZOOM TECHNOLOGIES INCORPORATED (NASDAQ: ZOOM)

"Up 19.82% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/ZOOM.php

 

Zoom Technologies is a holding company with subsidiaries that engage in the manufacturing, research and development, and sale of electronic and telecommunication products for 3rd generation mobile phones, wireless communication circuitry, and related software products. Zoom Technologies' subsidiary, Jiangsu Leimone, owns a majority stake of TCB Digital, which offers highly customized and high quality Electronic Manufacturing Service (EMS) for Original Equipment Manufacturer (OEM) customers and also designs and manufactures its own brand of mobile phones under the Leimone brand.

 

ZOOM News:

 

November 16 - Zoom Technologies Reports Third Quarter 2009 Financial Results

 

* Quarterly revenue increased 204% year over year to $55.29 million

* Quarterly net income increased 138% year over year to $1.73 million

* Full year 2009 revenue guidance increased to between $185 and $195 million

* Full year 2010 net income guidance in the range of $10.75 to $11.25 million on adjusted basis

* Continued listing on Nasdaq, under ticker "ZOOM" following share exchange with Gold Lion Holdings Ltd.

* Entered into an agreement with China Telecom to distribute LEIMONE mobile phones

 

Zoom Technologies, Inc. (Nasdaq: ZOOM) a leading China based manufacturer of mobile phones and other mobile electronic products, reported financial results for the third quarter ended September 30, 2009.

 

Mr. Lei Gu, Chairman and Chief Executive Officer of Zoom Technologies, commented, "We are delighted to report another quarter of tremendous year over year growth and our first financial results as a public company. The third quarter marks our listing on the Nasdaq following the share exchange with Gold Lion Holding Ltd. Our ability to accomplish this transaction and subsequent $10 million private placement during such a challenging macroeconomic environment reflects our strong growth prospects for 2010 and beyond. We are extremely pleased, as a newly traded public company, to attract quality institutional investors and execute this transaction."

 

For the third quarter of 2009, Zoom reported net revenue of $55.29 million, up 204% over $18.16 million for the third quarter 2008, and up 4.06% sequentially from $53.13 million in the second quarter 2009. Net income for the third quarter of 2009 was $1.73 million as compared to net income of $0.73 million for the third quarter of 2008. The robust revenue growth was driven by strong demand from our EMS customers and supported by healthy macroeconomic conditions in China.

 

Gross profit for the third quarter 2009 rose 55.0% to $3.03 million, compared to $1.95 million for the third quarter of 2008. Gross profit as a percentage of revenue for the third quarter of 2009 was 5.5%, compared to 10.8% for the same period of the prior year. The compression in gross margins is due to the competitive pricing necessary to capture a significant increase in business activities.

 

For the first nine months of 2009, Zoom reported net revenue of $137.24 million, up 234% over $41.14 million for the first nine months of 2008. Net income for the nine months ended September 30, 2009 was $4.35 million compared to net income of $1.73 million for the first nine months of 2008.

 

Mr. Gu continued, "Also during the third quarter, we were extremely excited to establish a distribution agreement with China Telecom, one of the top mobile phone operators in China. The distribution of our LEIMONE mobile phones demonstrates our capabilities in product development and the strength of the LEIMONE brand name in China. We believe our alliance with China Telecom will continue to facilitate the expansion of our high-quality products in the China market. We believe we are now poised to grow with the rapidly expanding China mobile phone market, pursue additional projects, and produce mobile products for top tier Chinese mobile phone companies. Additionally, the diversity of our product offering combined with our sound execution and delivery in challenging market conditions further improves our market position in China. Thus far, Zoom Technologies has delivered its LEIMONE phones to the Shanghai, Tianjin, Liaoning, Gangsu, Yunnan and Jiangxi Provinces."

 

The company upwardly revised its full year 2009 revenue guidance to between $185 million and $195 million and net income to between $6.0 million and $6.2 million, as compared to previous guidance of $145 million and $155 million in revenue and $5.9 million and $6.1 million in net income.

 

Looking ahead, Mr. Gu commented, "The funds raised from the recently completed private placement allows us to add new manufacturing lines for 3G mobile phones, expand our capacity and continue to fuel our growth in the China handset market. With this increased production, we now expect full year 2010 net income to be in the range of $10.75 million to $11.25 million on an adjusted basis, which is prior to deductions from non-cash equity based compensation charges."

 

Conference Call Details

 

The dial-in numbers are +1-877-407-9039 for US domestic callers and +1-201-689-8470 for international callers. After the live webcast, the replay will remain available on Zoom's website through December 16, 2009. In addition, a telephonic replay of the call will be available through November 30, 2009. The replay dial-in numbers are +1-877-660-6853 for US domestic callers and +1-201-612-7415 for international callers. The account number to access the replay is 3055 and the conference ID number is 337711.

 

CONOLOG CORPORATION (NASDAQ: CNLG)

"Up 16.78% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/CNLG.php

 

Conolog Corporation is a provider of digital signal processing and digital security solutions to electric utilities worldwide. The Company designs and manufactures electromagnetic products to the military and provides engineering and design services to a variety of industries, government organizations and public utilities nationwide. The Company’s INIVEN division manufactures a line of digital signal processing systems, including transmitters, receivers and multiplexers.

 

CNLG News:

 

November 13 - Conolog Reports Results for Fiscal Year Ended July 31, 2009

 

Conolog Corporation (Nasdaq: CNLG) reported its financial results for the fiscal year ended July 31, 2009.

 

Product revenue for the fiscal year ended July 31, 2009 totaled $1,485,298 an increase of 21.7% or $264,305 from the product revenue reported for the fiscal year ended July 31, 2008 of $1,220,993. The Company attributes this increase in revenues to an increase in sales.

 

Product cost (Material and Direct labor) for the fiscal year ended July 31, 2009 amounted to $470,392 or 31.7% of product revenues, compared to $467,081 or 38.2% for the fiscal year ended July 31, 2008. The Company attributes the decrease in the current year’s product cost percentage to the standardizing of costs to build our new PDR-2000 system and the outsourcing of assemblies.

 

For fiscal year ended July 31, 2009 the Company, in compliance with its inventory management policy, the Company recognized $82,138 of cost relating to obsolete inventory parts. This compares to $112,171 of obsolete inventory parts expensed during the fiscal year July 31, 2008.

 

Total Operating expenses for fiscal July 31, 2009 were $2,672,943 a decrease of $1,700,135 from the $4,373,078 reported for fiscal July 31, 2008. The Company attributes this decrease to the forgiveness of Officers’ salary, reduced legal fees and a decrease in the value of stock compensation costs.

 

Other expenses for the fiscal year ended July 31, 2009 decreased by $2,540,274 to $695,995 from $3,236,269 for fiscal July 31, 2008. Included in this expense is a non-cash expense related to the induced conversion benefit of $552,370; a non-cash interest expense related to conversion of debt for $286,584; and the amortization of fees related to the conversion of debt for $123,274.

 

As a result of the foregoing, the Company reported a net loss applicable to common shares of $2,354,032 or $0.98 per share for fiscal 2009, compared to a net loss applicable to common shares of $6,967,606 or $23.49 per share (as restated for the stock reversal for fiscal 2009.

 

*The net loss applicable to common shares for fiscal 2008 has been restated to reflect the one-for-five reverse split of the Company’s common stock, approved by the shareholders on February 25, 2009. Total shares outstanding were 1,842,485 and 558,448 (as adjusted to reflect the reverse splits) for the years ended July 31, 2009 and 2008, respectively.

 

HELICOS BIOSCIENCES CORPORATION (NASDAQ: HLCS)

"Up 10.94% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/HLCS.php

 

Helicos BioSciences is a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets. Helicos' proprietary True Single Molecule Sequencing (tSMS)(TM) technology allows direct measurement of billions of strands of DNA, enabling scientists to perform experiments and ask questions never before possible. Helicos is a recipient of the $1,000 genome grant and is committed to providing scientists the tools to unlock the era of genomic medicine. The company's corporate headquarters are located at One Kendall Square, Building 700, Cambridge, MA 02139, and its telephone number is (617) 264-1800.

 

HLCS News:

 

November 17 - Helicos BioSciences Announces the Sale of a Helicos® Genetic Analysis System to the Leiden University Medical Center in the Netherlands

 

Helicos BioSciences Corporation (Nasdaq: HLCS) announced the sale of a Helicos® Genetic Analysis System to a collaborative Dutch research group led by the Leiden University Medical Center (LUMC), further including the medical centers of Amsterdam (AMC) Groningen (UMCG) and Rotterdam (Erasmus MC) and funded by a grant from NWO, the Netherlands Organization of Scientific Research. The system will be installed at the Leiden Genome Technology Center (LGTC), headed by Professor Johan den Dunnen, a leader in the fields of genomic research and technology.

 

“We are very proud to have LUMC as a customer. They have a strong tradition of adopting breakthrough technologies and have seen the unique benefits of single molecule analysis first-hand.” stated Ron Lowy, Helicos Chief Executive Officer.

 

The relationship between the medical center and Helicos began with a collaboration in which researchers at the LUMC’s Forensic Laboratory (FLDO) provided the company with ancient human DNA samples for analysis using Helicos’ revolutionary True Single Molecule Sequencing (tSMS)™ technology. Unlike alternative, amplification-based, next-generation sequencing technologies, Helicos’ tSMS approach provided informative human sequences from these ancient remains, demonstrating the technology’s unique ability to analyze highly degraded and compromised DNA samples. The project was led by Professor Peter de Knijff and graduate student Eveline Altena. The resulting data were reported at various conferences in September and October of 2009, including at the American Society of Human Genetics Conference in Honolulu. The data are being prepared for publication.

 

“Based on our initial results with another technology, we were not expecting to get much information from these highly degraded samples. Helicos was able to provide us with a surprisingly high proportion of human sequence information from these historical human remains, allowing us to determine their ancestry and relatedness for the first time. This was beyond our greatest expectations.” said LGTC’s Johan den Dunnen.

 

The Helicos Genetic Analysis System is the world’s first and only commercially available, single molecule sequencing technology, and enables scientists to conduct revolutionary studies in the fields of genome biology, cancer research, common diseases, and microbiology without DNA ligation or amplification. Genetic analysis with Helicos’ technology eliminates the biases, complexity and errors introduced by DNA amplification, requires minute amounts of starting material, is amenable to the analysis of degraded nucleic acids, and provides the most direct and accurate view of biological samples.

 

ABOUT LUMC

 

Leiden University Medical Centre (LUMC) is a center for medical innovation, committed to the advancement of health care through research and innovation. Its focus is on translational research to accelerate the trajectory from the laboratory findings to clinical application and into the market place. As academic medical center it provides patient care and medical education. LUMC performs 15,600 daytime treatments and 20,000 hospital admissions yearly, and employs 7,000 people.

 

POWER 3 MEDICAL PRODUCTS INCORPORATED (OTCBB: PWRM)

"Up 15.79% in morning trading"

 

Detailed Quote: www.otcpicks.com/quotes/PWRM.php

 

Power3 Medical Products Inc. is a leading Bio Medical company engaged in the commercialization of cancer and neurodegenerative disease biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3's patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas. The Company continues to evolve and enhance its IP portfolio.

 

PWRM News:

 

September 18 - Emerging Stock Report Initiates Independent Research Coverage On Power3 Medical Products, Inc.

 

Emerging Stock Report, a leading provider of sector specific independent investment research, initiated coverage on Power3 Medical Products, Inc. (OTCBB: PWRM). Emerging Stock Report is currently offering a complimentary trial subscription. To view the company's research go to http://www.emergingstockreport.com.

 

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov/ and FINRA at http://www.finra.org/.

Disclosure: OTCPicks has been compensated five thousand dollars from a non-controlling third party for SNBP advertising and promotional services. Previously OTCPicks.com has been compensated three thousand dollars by a third party (WFWS Consulting) for SNBP advertising and promotional services. OTCPicks.com has been compensated two hundred seventy five thousand free trading shares by a third party for OPSY advertising and promotional services. OTCPicks.com has not been compensated for VGPR advertising and promotional services, but OTCPicks principles have purchased five hundred thousand free trading shares in the open market and reserves the right to sell any or all shares at any time. OTCPicks has been compensated seven thousand five hundred dollars from a non-controlling third party (BlueWave Advisors) for AMNP advertising and promotional services. OTCPicks.com has been previously compensated seven thousand five hundred dollars by a third party for BMGP advertising and promotional services. OTCPicks.com has been compensated twelve thousand five hundred dollars by a third party for BMGP advertising and promotional services. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. OTCPicks.com is a website partially owned by BlueWave Advisors, LLC, a financial public relations firm. BlueWave Advisors, LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.